A cell-permeable adenosine analog (5-aminoimidazole-4-carboxamide ribonucleoside, CAS 2627-69-2) that is phosphorylated intracellularly to ZMP, an AMP mimetic that allosterically activates AMP-activated protein kinase (AMPK). Downstream activation shifts cellular metabolism toward catabolic pathways — glucose uptake, fatty-acid oxidation, mitochondrial biogenesis — recapitulating aspects of exercise signaling. Not a peptide; studied preclinically as an exercise mimetic and in ischemia-reperfusion protection. Banned by WADA since 2009 as a metabolic modulator.
For research purposes only. Not medical advice.
Ruo Bio currently lists AICAR at $0.72/mg, the lowest indexed price across 2 tracked research peptide vendors.
AICAR ranges from $0.72/mg to $1.18/mg across 2 listings from 2 research peptide vendors, normalized to USD per milligram and refreshed daily.
2 research peptide vendors currently list AICAR on PeptideScouter. We track 2 active listings across size and kit variants.
AICAR's CAS Registry Number is 2627-69-2.